CohBar, Inc. (CWBR) Q4 2021 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon. My name is Kyle and I will be your conference operator today. At this time, I'd like to welcome everyone to CoBAR's fourth quarter and full year 2021 financial results conference call. All lines have been placed on mute to eliminate background noise. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. Now, I'd like to turn the call over to Jordan Tarazi, Director of Investor Relations at COBAR. Thank you, Kyle, and thank you, everyone, for joining COBAR's fourth quarter and full year 2021 financial results conference call. Joining me on today's call is Joe Surrett, COBAR's Chief Executive Officer, and Jeff Buno, COBAR's Chief Financial Officer. I would also like to take this opportunity to welcome Dr. Nick Vlahakis, COBAR's newly appointed Chief Medical Officer, who will also be providing remarks today. Following our collective remarks, we will conclude with Q&A, at which time Dr. Kent Greinstaff, SVP of Research, will also join us. COBRA's financial results press release was issued earlier today and may be downloaded from our website at cobra.com. Before we begin, I'd like to take a moment to remind listeners that the remarks on today's conference call may include forward-looking statements within the meaning of the securities laws. These forward-looking statements include but are not limited to statements regarding the company's business and financial strategies, plans and expectations for its pipeline product candidates, the therapeutic and commercial potential of the company's pipeline product candidates, and other therapeutics from our MITO Plus platform, statements rega...